病毒学是医疗保健系统的重要部分之一。它在疫苗开发、诊断、治疗等方面有着广泛的应用。的病毒学市场参与者不断参与产品创新和开发,以维持市场竞争。他们探索产品创新的各个领域。例如,对于 COVID-19,市场参与者正在大力投资疫苗、检测试剂盒以及其他相关产品和服务的开发。以下是与病毒学市场相关的一些市场动态。
- 2021 年 8 月,美国食品和药物管理局 (FDA) 批准了首款 COVID-19 疫苗,名为辉瑞 BioNTech COVID-19 疫苗。它将作为 ComiRNAty (Koe-mir’-na-tee) 上市。该疫苗旨在预防 16 岁及以上个体的 COVID-19 疾病。它还可根据紧急使用授权 (EUA) 提供。
- 2021 年 4 月,CerTest Biotec 为 BD MAX 系统推出了具有 CE 标志的 COVID-19 诊断测试。
- 5 月2020 年,Bio-Rad 获得 FDA 批准用于 COVID-19 总抗体测试的紧急使用授权。
- 2020 年 5 月,Aalto Bio Reagents 推出了新型重组真核 SARS-CoV-2 S1-S2 刺突蛋白。
市场洞察不断增长微创和无创美容手术的采用推动病毒学市场增长人类免疫缺陷病毒 (HIV)、流感病毒、寨卡病毒、埃博拉病毒、SARS-CoV-2 和脊髓灰质炎病毒等病毒感染大量人群世界各地的人口。随着病毒不断变异和进化,耐药性成为人类和动物病毒感染管理的重大挑战。病毒根据其类型通过各种介质传播。例如,有些病毒引起呼吸道病毒性疾病,如流感、普通感冒、呼吸道合胞病毒感染等,通过咳嗽或打喷嚏产生的飞沫传播,而有些胃肠道病毒性疾病则通过直接接触感染者的粪便传播。人或通过受污染的食物或水。根据联合国艾滋病规划署的数据全球艾滋病毒和艾滋病毒艾滋病统计数据显示,2020年全球有超过3770万人感染艾滋病毒。
国际病毒分类委员会(ICTV)宣布引起新冠肺炎的新型冠状病毒-19 于 2020 年 2 月被命名为严重急性呼吸系统综合症冠状病毒 2 (SARS-CoV-2)。该病毒自爆发以来已经发生了几次突变,这加剧了 COVID-19 大流行的严重性。例如,根据美国疾病控制与预防中心 (CDC) 的 COVID-19 追踪数据,截至 2021 年 8 月,每 10 万人中的 7 天病例率为 299.4,美国报告了超过 164,952 例新病例。此外,根据欧洲疾病预防和控制中心的数据,截至 2021 年 8 月,欧洲经济区 (EEA) 的 COVID-19 病例总数达到约 36,307,572 例。因此,病毒感染流行率的上升正在推动病毒学市场的增长。 基于类型的见解基于类型,病毒学市场进一步细分为诊断测试、病毒感染控制技术、抗病毒治疗和干扰素。到2021年,诊断测试领域预计将占据最大的市场份额,而病毒感染控制技术领域预计在2021年至2028年期间复合年增长率最高。 < h2>按产品划分的病毒学市场(2021 年和 2028 年)
基于应用的见解基于应用,市场细分为皮肤和软组织感染、呼吸道感染、胃肠道感染、性传播疾病、尿路感染等。 2021 年,呼吸道感染领域预计将占据最大的市场份额,预计 2021-2028 年复合年增长率最高。
战略见解在病毒学市场运营的公司强调采用产品创新策略来满足世界各地不断变化的客户需求,这也使他们能够在全球市场上保持自己的品牌声誉。 病毒学市场 –细分 按类型
- 诊断测试
- DNA病毒测试
- RNA病毒检测
- 其他
- 病毒感染控制技术
- 主动预防
- 被动预防
- 抗病毒治疗
- 杀病毒剂
- 抗病毒剂
- 免疫调节剂
- 干扰素
- 皮肤和软组织感染
- 呼吸道感染
- 胃肠道感染
- 性传播疾病
- 泌尿道感染
- 其他
- 医院
- 诊断实验室
- 制药和生物技术公司
- 研究和学术机构
- 北美洲
- 美国
- 加拿大
- 墨西哥
- 欧洲
- 法国
- 德国
- 意大利
- 英国< /li>
- 西班牙
- 欧洲其他地区
- 亚太地区
- 中国
- 印度< /li>
- 韩国
- 日本
- 澳大利亚
- 亚太地区其他地区
- 中部东部和非洲
- 南非
- 沙特阿拉伯
- 阿联酋
- MEA其他地区
- 南美洲和中美洲
- 巴西
- 阿根廷
- 其他骗局
- 雅培
- 强生公司约翰逊服务公司
- F. Hoffmann-LA Roche Ltd.
- Thermo Fisher Scientific, Inc.
- Qiagen < li>Illumina, Inc.
- 西门子股份公司
- 葛兰素史克公司 < li>Gilead Sciences, Inc.
- AbbVie, Inc.各自网站上给出的版权名称。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Virology is a detailed study of viruses that focuses on the structure, classification, evolution, and genetics of viruses. The virology market caters to the prevention and development of treatments for several viral diseases. The increasing prevalence of emerging infectious diseases (EIDs)—chikungunya, Ebola, West Nile virus, severe acute respiratory syndrome (SARS), and Lyme disease is driving the growth of the virology market. The key driving factors for the market growth are, rising prevalence of viral infections and other infectious diseases along with growing awareness about diagnosis and treatment of the disease.
The factors that are driving and restraining factors that will affect virology market in the coming years. Factors such as rising prevalence of viral infectious diseases and increasing product launches, are driving the market growth. However, availability of alternative products and high cost of production of products are likely to hamper the growth of the market.
The virology market majorly consists of the players such as Abbott, Johnson & Johnson Services, Inc., F. Hoffmann-LA Roche Ltd., Thermo Fisher Scientific, Inc., Qiagen, Illumina, Inc., Siemens AG, GlaxoSmithKline Plc, Gilead Sciences, Inc., and AbbVie, Inc. are amongst others.
The global virology market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America dominates the global virology market due to factors such as technological advancement, increasing product launches, and increasing investment in healthcare and research. The transmission of infectious diseases globally has made diagnosis mandatory for travelers. Today, the diseases are spreading faster around the world, which is further bolstering the demand for diagnostic tools as they can help control the outbreak at an early stage. For instance, in September 2019, the FDA approved OraQuick Ebola Rapid Antigen Test, a new rapid diagnostic test for Ebola in the US.
Asia Pacific is expected to be the fastest growing region Asia Pacific is expected to expand at a high growth rate due to large patient population, increasing government support to provide better healthcare services, and increasing product launches by market players. For instance, in 2018, Cepheid initiated the HBDC Access Program1 for the diagnosis of HIV, viral hepatitis (HCV), and human papillomavirus (HPV)2 at a relatively lower price. The company is aiming to make tests that would be more accessible to lower-income countries.
The global virology market based on based on type is segmented into diagnostic test, viral infection controlling techniques, antiviral therapeutics, and interferons. In 2021, Antiviral Therapeutics segment is estimated to account for the largest market share in the global virology market. the growth can be attributed to increasing prevalence of human immunodeficiency virus (HIV) and increasing research and development investment by private and public companies for antiviral drugs.
The List of Companies - Virology Market
- Abbott
- Johnson And Johnson Services, Inc.
- F. HOFFMANN-LA ROCHE LTD.
- THERMO FISHER SCIENTIFIC INC.
- QIAGEN
- Illumina, Inc.
- Siemens AG
- Glaxosmithkline Plc
- Abbvie Inc.
- Gilead Sciences, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Sep 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Sep 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Sep 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)